Bone News and Research

RSS

NYIT professor awarded multi-year NIH grant for bone-healing research

NYIT has been awarded $442,000 to pursue research into a gene critical in the formation and healing of bones.

5 Sep 2017

Largest ever genetic study paves way for potential osteoporosis treatment

Scientists are honing in on a potential treatment for osteoporosis, after performing the largest ever genetic study of the common age-related bone-thinning disease.

5 Sep 2017

Infectious bacteria in children's throats strongly linked to bone and joint infection

The presence of the bacterium Kingella kingae in children's throats was strongly linked to bone and joint infection with the same bacterium, according to new research published in CMAJ.

5 Sep 2017

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML).

1 Sep 2017

Spot Leukaemia campaign launched to reduce delays in diagnosis

A UK leukemia charity, Leukaemia CARE, has launched the Spot Leukaemia campaign to raise awareness of the signs and symptoms of leukemia after a survey revealed that leukemia diagnoses are commonly delayed due to poor understanding.

1 Sep 2017

Study explores periodontal status of patients with Chédiak-Higashi syndrome

The International and American Associations for Dental Research have published an article titled "Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response" in the JDR Clinical & Translational Research.

31 Aug 2017

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.

31 Aug 2017

St. Jude creates world’s largest collection of pediatric solid tumor samples

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children's Research Hospital scientists have created the world's largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.

31 Aug 2017

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Pioneering cancer gene therapy gets green light — and $475,000 price tag

The country's first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced.

30 Aug 2017

New biomedical tool using nanoparticles could improve therapies for many diseases

A new biomedical tool using nanoparticles that deliver transient gene changes to targeted cells could make therapies for a variety of diseases - including cancer, diabetes and HIV - faster and cheaper to develop, and more customizable.

30 Aug 2017

FDA approves first cell-based gene therapy for use in the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

30 Aug 2017

FDA grants accelerated approval to new treatment for children with Chagas disease

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease.

29 Aug 2017

Women with PCOS have higher risk of developing type 2 diabetes, study reveals

Women who have polycystic ovary syndrome (PCOS) have a higher risk of developing type 2 diabetes (T2D) and are diagnosed at an earlier age with the condition, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

29 Aug 2017

Bone News and Research

NYIT professor awarded multi-year NIH grant for bone-healing research

Largest ever genetic study paves way for potential osteoporosis treatment

Infectious bacteria in children's throats strongly linked to bone and joint infection

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Spot Leukaemia campaign launched to reduce delays in diagnosis

Study explores periodontal status of patients with Chédiak-Higashi syndrome

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

St. Jude creates world’s largest collection of pediatric solid tumor samples

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Pioneering cancer gene therapy gets green light — and $475,000 price tag

New biomedical tool using nanoparticles could improve therapies for many diseases

FDA approves first cell-based gene therapy for use in the United States

FDA grants accelerated approval to new treatment for children with Chagas disease

Women with PCOS have higher risk of developing type 2 diabetes, study reveals

Research may lead to first-ever pharmacological treatment for rare genetic bone disease

Tiny tears in membranes of bone cells may be key to strong bones

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Scientists discover way to treat severe inflammation from mosquito-borne diseases

Boosting blood levels of bone-derived hormone may reverse age-related memory loss

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News